Article

Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson’s Disease

2022-03-16

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objective</h4> Using a multi-cohort, Discovery-Replication-Validation design, we sought new plasma biomarkers that predict which PD individuals will experience cognitive decline. <h4>Methods</h4> In 108 Discovery Cohort PD individuals and 83 Replication Cohort PD individuals, we measured 940 plasma proteins on an aptamer-based platform. Using proteins associating with subsequent cognitive dec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ee17a398-9bef-56ed-bfc1-8f9861b4f502
DOI: 10.1101/2022.03.16.22272456

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson’s DiseaseDOI 10.1101/2022.03.16.22272456Read

Characterization of Parkinson’s disease using blood-based biomarkers: A multicohort proteomic analysisSemantic proximity Read

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.Semantic proximity Read

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluidSemantic proximity Read

Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s diseaseSemantic proximity Read

Identification of a novel proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSFSemantic proximity Read

Machine learning-based prediction of cognitive outcomes in de novo Parkinson's diseaseSemantic proximity Read

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.Semantic proximity Read

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.Semantic proximity Read

Association between the <i>LRP1B</i> and <i>APOE loci</i> and the development of Parkinson’s disease dementiaSemantic proximity Read

Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's DiseaseSemantic proximity Read

Genome-wide association studies of cognitive and motor progression in Parkinson's diseaseSemantic proximity Read

What can biomarkers tell us about cognition in Parkinson's disease?Semantic proximity Read